<
Which varieties are expected to enter the six major focus of the new medical insurance directory guidance
Release time: 2016-08-25 & nbsp & nbsp & nbsp Source: Anonymous
  A new round of national medical insurance catalog adjustment that the industry and parties are calling are finally on the agenda,July 22,The Ministry of Human and Social Security of the National Human and Social Security said at the regular press conference in the second quarter,Adjust the medical insurance drug directory as a key job this year。
 
  This also means,The selection of varieties of the new medical insurance catalog will be launched in the second half of this year。
 
  Lotten the whole body
 
  National Catalog Update annual jump
 
  The first national version of the medical insurance directory was introduced in 2000。In the early days of the planned economy era and the market economy era,The country still implements a medical security mode mainly based on public medical care,But with the in -depth marketization of marketization,Public medical care of the planned economic model is difficult to adapt to the development of society。The Interim Measures for the Management of the Scope of Medicine for Medical Insurance in Urban Workers "was announced in 1999,2000 version of the national medical insurance directory is introduced。
 
  To regulate medication,Reduce the burden on patients,2004、In 2007 and 2009, the National Social Security Department led the 3rd version of the updated medical insurance directory。Take the latest 2009 version of the directory as an example,2009 version of the directory compared to the 2007 version,Western medicine varieties expanded from 1031 to 1164,The number increased by 12.9%; the varieties of traditional Chinese medicine expanded from 823 to 987,Numbers increased by 19.9%。
 
  According to the previous frequency,General insiders believe that the medical insurance directory will be updated every 3 years,This means that there may be new medical insurance directory adjustments from 2012-2013。At that time, many companies thought that the directory was adjusted at,Enter the directory to enter the directory and eager to try。But,Many unofficial medical insurance directory will be adjusted every year after every year,But jump tickets every year,Make these companies invest a lot of manpower stake sports betting appstake betting appand material resources without results。
 
  Because the 2009 version of the directory is mainly considered the medicine listed before 2008,This has led to a large number of innovative drugs in 8 years from 2008 to the present、Imitation drugs and imported drugs cannot enter the directory,Clinical use restrictions,It also increased the burden on the patient。
 
  Relevant departments formulated as the directory,Of course, it is also very clear about the problem that the new directory is not promulgated。But because the directory formulation is very important,Lotten the whole body,Plus to avoid possible benefits to rent,Therefore, the relevant departments are very cautious about the formulation of the directory。
 
  Complex mathematics questions
 
  Medical insurance pressure PK incorporate more new varieties
 
  Of course,Directory is delayed without adjustment.,At present, the growth rate of the medical insurance fund expenditure is significantly faster than the growth rate of income。According to the "China Medical and Health Development Report 2015" released in March this year,If China's medical insurance model has not changed greatly in the short term,Soon China's medical insurance funds will turn to loss,The gap will increase increasingly。Considering the aging intensification,This problem will be more serious。
 
  Do not consider drug economics,From the perspective of treatment costs,Newly approved drugs, especially imported drugs and domestic innovative drugs in a single day or treatment treatment costs are significantly higher than traditional drugs; and from clinical perspective,Many of these drugs should be included in medical insurance。This means,If the new directory rejection of these varieties will undoubtedly bring a lot of criticism,In addition, it will further increase the pressure of medical insurance payment。
 
  How to include as much as possible in the new variety as much as possible to reduce the payment pressure of medical insurance,It is undoubtedly a complex mathematical question。
 
  but but,Medical reform in recent years has proposed a lot of solutions,Pay with a single disease、Pharmaceutical ratio、zero bonus、Two lines of revenue and expenditure and standardized clinical medication paths, etc., have been gradually expanded,and achieved some effects。
 
  On the other hand,This year, the country has successfully completed three national negotiations with innovative drugs,The average price reduction of 3 varieties is about 60%。This means that many companies are willing to exchange for the support of medical insurance through significant price reductions。So,Innovative medicine for the future to enter the medical insurance directory,You can consider carrying out national price negotiations first,The variety passed directly into the directory。
 
  New directory screening guidelines
 
  Analysis of the problem of six major focus
 
  So,What are the tendencies of drug selection in the new medical insurance stake online sports bettingdirectory? Let us analyze stake betting appthe several issues that the industry is most concerned about,Try to solve the wind direction of the medical insurance directory adjustment!
 
  1. Innovative drugs enter the medical insurance directory?
 
  Willing & ldquo; the opportunity of the price exchanges & rdquo;
 
  Patented drugs, especially domestic innovative drugs, have always been high。But the general view of the previous view,If the innovative drug enters the medical insurance,It will significantly push the medical insurance expenditure。
 
  The establishment of the national drug price negotiation system has solved this problem to a certain extent。The high -priced strategy of innovative drugs is derived from its general research and development costs higher,It is difficult to recover R & D investment in the case of limited drug users; but,It will undoubtedly expand the sales volume of drugs by entering the medical insurance,& ldquo; Price exchanging volume & rdquo; It is undoubtedly a good choice for enterprises。
 
  So,For those innovative medicines that are willing to reduce price significantly,You can consider incorporating it in this medical insurance directory adjustment。
 
  2. Policy support for Chinese medicine:
 
  Chinese medicine injection、Auxiliary medication and Chinese and Western compound preparations are difficult to speak
 
  A large number of support documents encouraged and supported the development of Chinese medicine at the national level,Including Chinese medicinal materials research、Drug composition research、Drug activity research, etc.。
 
  but,The use of proprietary Chinese medicines in the clinic is still subject to many restrictions,Especially in recent years, the state has approved many exclusive Chinese medicine extracts、New drugs for monomers or compound preparations。Many of these varieties cannot enter the medical insurance directory。
 
  Of course,It is not appropriate to include these varieties in the new version of the medical insurance directory,But some of them are exactly precise、Safety and reliable, especially the varieties that have entered the domestic high -level disease treatment guide or clinical path.。
 
  On the other hand,Chinese medicine injection、Auxiliary medication and Chinese and Western compound preparations are hard to speak。The abuse of traditional Chinese medicine injection is more serious,Especially some Chinese medicine cardiovascular and cerebrovascular injections lack clear indications,At the same time, the safety of many Chinese medicine injections is more serious,Abuse increases the possibility of adverse events; some auxiliary medication,occupied huge medical insurance funds,But the effect is not significant;。These varieties entering the new medical insurance directory are not difficult,Even the possibility of the variety that has entered the variety can be kicked out of the directory。
 
  3. Entering provincial medical insurance directory varieties in many places:
 
  Not big opportunities,The opportunity to sell a lot is greater and faces the pressure reduction pressure
 
  Considering the selection of medical insurance directory stake online sports bettinghas always been a work carried out by experts nationwide,Therefore, the varieties that have stake online sports bettingentered the provincial medical insurance directory in many places undoubtedly have a lot of opportunities。
 
  Where,Those varieties with a larger market scale are greater,Although the pressure of medical insurance funds is not small,But medical insurance is more important to social livelihood attributes,The income of large sales varieties can reduce the overall medical burden of patients。Of course,These varieties will also face the pressure of price reduction。
 
  4. Will the price of medical insurance payment be implemented?
 
  It has to be observed, and it may be introduced at the regional level
 
  Due to the release of drug pricing,The original medical insurance reimbursement model can no longer adapt to the new drug price system,In the new round of drug directory adjustment,Will it be very concerned about the medical insurance payment industry directly。
 
  For example, there is a point of view,The new medical insurance payment model will be paid uniformly on the same universal drug,This will undoubtedly have a huge impact on the original research medicine。In addition,There is also a call hoped to use the mode of payment by medical insurance。
 
  but but,Considering the status quo of the market,It is difficult to expand at the national level in the short term,And the medical insurance payment price is due to medical insurance situations in various places、Payment level thousands of differences,It is difficult to unify,It may not rule out the possibility of the regional level。
 
  5. Do you support OTC varieties into medical insurance?
 
  There is a lot of controversy,But the possibility of the marginalization of this type of medical insurance
 
  Many information recently came out,OTC variet。Conservative views that a new round of medical insurance will not increase OTC varieties,and a more aggressive point of view, it is said that OTC varieties will be kicked。
 
  For these views,I don’t agree with it very much。For medical insurance itself,Not simply aimed at major illness medical insurance for major diseases,For slow diseases、Early prevention and control of the disease is also very important。If the OTC variety is marginalized in the upper medical insurance,It will make many patients no longer choose OTC to buy medicine,and go directly to the hospital for treatment,This will undoubtedly further increase the pressure of medical institutions。On the other hand,OTC variety for disease control、It is great value to prevent its progress,If the medical insurance support for OTC varieties is reduced,It will also interrupt or ignore the control of the disease,Lead of minor disease and major diseases,Disease complications,This undoubtedly caused the inefficiency of medical security。So,Medical medical treatment is important,But it is not wise to support medical treatment with OTC to support major diseases。
 
  6. How many catalogs do you have?
 
  Will it integrate with Xinnonghe Catalog? How to coordinate with the base medicine directory?
 
  Too many directory is Stake Sports Bettinga problem faced by both pharmaceutical factories and medical institutions,Many people don’t understand My stake betting appwhy there are so many medicines for medical insurance -related medicines。Whether the new round of medical insurance directory can integrate several major directory is highly anticipated。
 
  Before that,Shandong and other areas have been piloted with three guarantees and one。But at the national level,Medical Insurance Directory and New Rural Co -Catalog can be integrated with it.。
 
  Due to the problem of multiple management in the directory,So the integration of the directory undoubtedly requires the coordination and balance of the national level,Looking at it now,The directory is still led by the Ministry of Human Resources and Social Security,This means that it is difficult to quickly integrate each directory in the short term。
 
  In addition,Early mode will directly include the patent catalog in the category of medical insurance,But the new round of basic medicine directory has many,It is estimated that so many varieties are included in the reimbursement ratio of highly reimbursement.,It is possible that some varieties will be classified as a medical insurance category to reduce the pressure of medical insurance payment。